Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
41 Cards in this Set
- Front
- Back
What kind of clot does an arterial thrombus arise from? What pathologies does it cause?
|
White clot: platelets and fibrin
MIs and CVA (stroke) |
|
What kind of clot does a venous thrombus arise from? What pathologies does it cause?
|
Red clot: fibrin, platelets, RBC, other cellular elements
Pulmonary embolism, DVT Classically described by Virchow's Triad: Blood stasis, Endothelial injury, Hypercoagulability |
|
What are the intrinsic and extrinsic pathways and where do they meet?
|
Both clot formation pathways to link platelets with fibrin to make clot.
Intrinsic: Factor 12 -> 11, 9, 8, evaluate by PTT = Partial Thromboplastin Time Extrinsic: Factor 7, evaluate by PT = Prothrombin Time Final Common pathway: 10 -> 5, 2, Prothrombin, fibrinogen, fibrin clot... |
|
What is the MOA of unfractionated heparin (UFH)?
|
Accelerates antithrombin III activity (anticoagulant) -- breaks down thrombin and inactivates tissue factors
Interferes with platelet aggregation at HIGH doses Also: inc lipoprotein lipase activity, inhibit smooth cell proliferation |
|
What are the uses of heparin (UFH)?
|
Venous thrombosis, PE, early in unstable angina and acute MI
Prophylaxis (surgery): prevent post-op DVT and PE Prophylaxis: clotting in blood transfusions, dialysis, blood samples DOC in PREGNANCY: does NOT cross placenta |
|
How is heparin (UFH) administered?
|
ONLY IV, subQ (immed/ short delay)
Half-life depends on dose |
|
How should you monitor heparin (UFH)?
|
APTT = Activated Partial Thromboplastin Time, dose adjust
Monitor skin lesions, thrombotic complications, UFH/platelets (HIT toxicity) |
|
What are the toxicities of heparin?
|
MC bleeding, dose dep (GP IIb/IIIa antagonism)
THROMBOCYTOPENIA: heparin associated/induced = HAT (benign, 2 days), HIT (serious, 1 wk) results from autoimmune rxn to UFH, thrombosis Also, LIVER tox, OSTEOPOROSIS (heparin binds osteoblasts, activate osteoclasts) |
|
Where is heparin (UFH) CI?
|
Severe thrombocytopenia (bleeding!)
|
|
What drug interactions does heparin (UFH) involve?
|
Digoxin, tetracycline, nicotine, antihistamine DECREASE effect
Anticoags, NSAIDs, ASA, dipyridamole, Plavix, direct thrombin inhibitors INCREASE effect OD! use ANTAGONIST Protamine sulfate to bind heparin and neutralize |
|
What are the 3 Low Molecular Weight Heparins (LMWH)?
|
Dalteparin, Enoxaparin, Tinzaparin
|
|
What is the MOA of LMWHs?
|
Bind and inactivate ONLY factor Xa
|
|
What are the uses of LMWHs?
|
Similar to heparin
Special: Renal failure, obesity, PREGNANCY DVT, PE, unstable angina and MI, surgery, hemodialysis |
|
How are LMWHs administered?
|
Subq
Also, must continue drug to continue effects |
|
How is LMWH monitored?
|
Does NOT need monitoring
|
|
What are the toxicites of LMWH?
|
Bleeding! (esp at injection site)
Thrombocytopenia (HIT) Osteoporosis Advantages: less side effects!!! Less HIT, less osteoporosis, minor bleeding |
|
What are the direct thrombin inhibitors?
|
Hirudin
Lepirudin - IRREV binds thrombin, kidneys Argatroban - REV binds, liver Bivalirudin - REV binds, kidneys ALL given IV |
|
What is the MOA of direct thrombin inhibitors?
|
Interacts directly with thrombin -- inhibits both CIRCULATING and CLOT-BOUND thrombin
|
|
What is the use of direct thrombin inhibitors?
|
Alternative to heparin in pts with HIT!
|
|
What is the side effect of direct thrombin inhibitors?
|
Bleeding!! high incidence
|
|
What is the direct Xa inhibitor and its MOA?
|
Fondaparinux - REV binds Xa to accelerate antithrombin III
|
|
What is the use of Fondaparinux? How is it administered?
|
Alternative to pts with HIT!
Subq, kidney |
|
What is the MOA of warfarin (coumadin)?
|
Inhibits hepatic synthesis of vitamin K-dependent CLOTTING FACTORS
Interferes with synthesis of anticoagulants, protein C & S |
|
What are the uses of warfarin (coumadin) as an anti-coagulant?
|
Prophylaxis/tx of venous thrombosis and PE
Cardiac dz, Atrial fib, prosthetic heart valve, rheumatic dz |
|
What are the kinetics of warfarin (coumadin)? When should you administer it?
|
Oral, good absorption
Takes time to see full effect (months) Start within 24 hours of heparin, tx overlap |
|
What should you avoid when taking warfarin (coumadin)?
|
Food high in vit K (leafy greens)!! don't binge.
Herbals increase anticoag effects: ginkgo, ginger, garlic, vit E, St Johns wart LOTS of drug interactions |
|
What kinds of toxicities does warfarin (coumadin) have?
|
BLEEDING!
Coumadin-induced SKIN NECROSIS Antidote: Frozen plasma (replaces clotting factors) |
|
Where is the use of warfarin (coumadin) CI?
|
PREGNANCY (crosses placenta)
Uncontrolled bleeding and GI ulcers |
|
How do you monitor the use of warfarin (coumadin)?
|
PT, expressed in INR = PTpt/PTnormal
INR ~2-3 |
|
What is the MOA of aspirin? What happens if you increase the dose of aspirin?
|
Irrev inhibits COX, prevents synthesis of thromboxane A2 -->inhibits platelet aggregation and vasoconstriction
IRREV - lasts life of platelet, 7-10 days Increased dose does NOT incr efficacy, INC BLEEDING TOX |
|
What is the MOA of dipyridamole?
|
Inhibits phosphodiesterase --> increase in cAMP in platelets which reduces aggregation
Stimulates prostacyclin, anti-platelet effects |
|
What is the use of dipyridamole?
|
Prevent embolization from heart valves (with Warfarin)
Reduce thrombosis in thrombotic dz (with Aspirin) |
|
What is the MOA of ticlopidine?
|
IRREV inhibits platelet ADP receptor, impairs activation of glycoprotein IIb/IIIa
|
|
What are the toxicities of ticlopidine?
|
SEVERE NEUTROPENIA: monitor CBC closely
|
|
What is the MOA of clopidogrel? What is the toxicity of clopidogrel?
|
IRREV inhibits platelet ADP receptor, impairs activation of glycoprotein IIb/IIIa
Well tolerated versus ticlopidine |
|
What is the MOA of prasugrel? What is the toxicity of prasugrel?
|
IRREV inhibits platelet ADP receptor, impairs activation of glycoprotein IIb/IIIa
Tox: Similar to clopidogrel BLACK BOX warning!! life-threatening bleeding risk in 1.3% pts |
|
What are the Glycoprotein IIb/IIIa receptor antagonists?
|
Eptifibatide, Tirofiban, ABCIXIMAB
Directly bind receptor, no platelet cross linking |
|
What is the use of Glycoprotein IIb/IIIa receptor antagonists? What are the toxicities of these drugs?
|
Acute coronary syndrome at high risk for further MI, ischemia
Bleeding and Thrombocytopenia (less than Heparin) |
|
What are the thrombolytics? What is their MOA?
|
Streptokinase, Urokinase, Alteplase, Anistreplase, Reteplase
Converts plasminogen to plasmin, which digests fibrin (all are tPA = tissue plasminogen activators except streptokinase) |
|
What is the use of thrombolytics?
|
Dissolve FORMED clot (also direct thrombin inhibitors do this)
|
|
What are the CIs of thrombolytics?
|
Bleeding risks: recent surgery, Serious GI BLEED within past 3 months, disorder
Cardiac: aortic dissection, acute pericarditis Previous stroke, intracranial problems Hx HTN (predisposed to have hypertensive brain bleeds) |